Oviva offers digital solutions for treating diabetes and obesity using a platform focused on behavior change.
Oviva has raised $233.7M in total funding. The most recent round was Series D. The last funding was announced in January 2026.
Oviva's investors include Temasek Holdings, Norrsken VC, Eight Roads Ventures, F-Prime, Partech.
Oviva is headquartered in Zürich, Switzerland.
Oviva offers digital solutions for treating diabetes and obesity using a platform focused on behavior change.
Oviva is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oviva — Funding & Investors." VCBacked, January 22, 2026, https://www.vcbacked.co/company/oviva. Accessed July 19, 2026.
VCBacked. (2026). Oviva — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/oviva
{{cite web |title=Oviva — Funding & Investors |url=https://www.vcbacked.co/company/oviva |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated